Most Recent
‘Contingency on contingency’: Judge won’t halt IP dispute over Abilify generic
Intellectual Property 2024-11-01 11:18 pm By Sam Matthews

The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Judge approves settlement in Retail Food Group class action
Class Actions 2024-10-31 11:39 pm By Sam Matthews

A judge has signed off on a class action settlement that will see Retail Food Group pay nothing to the current and former franchisees of its Michel’s Patisserie chain.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

JWS nabs Corrs Chambers pair for industrial relations team
Business of Law 2024-10-31 11:48 pm By Sam Matthews

Johnson Winter Slattery has bolstered the ranks of its industrial relations and employment team, luring a new partner and special counsel away from Corrs Chambers Westgarth. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Cipla attacks patent extension for Novo Nordisk weight loss drug
Intellectual Property 2024-10-30 11:01 pm By Andy Sidler

Cipla is opposing the extension of Novo Nordisk’s patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Government wants to stay 12-year-old dispute over Abilify generic
Intellectual Property 2024-10-30 11:12 pm By Cindy Cameronne

The Commonwealth has argued that a long-running dispute involving drug makers Otsuka, Bristol-Myers Squibb and Generic Health should be put on ice until the High Court rules in a separate matter.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

AstraZeneca sues to put the brakes on Brilinta generic
Intellectual Property 2024-10-29 11:33 pm By Andy Sidler

AstraZeneca has brought court proceedings to block Australian drug maker Pharmacor from making a generic version of its heart attack drug Brilinta. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Litigators of the week: Ashurst, Maurice Blackburn score big in epic legal battles
Maurice Blackburn 2024-10-25 11:11 pm By Cindy Cameronne

Years of hard fought litigation by axed Qantas ground crew and generic drug maker Sandoz ended in victory this week, thanks to legal eagles from Maurice Blackburn and Ashurst and their counsel. The week opened with a bang with a decision from Federal Court Justice Michael Lee in three landmark test cases by the Transport…

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

IP case over basmati rice to venture into ‘darker corners’ of trade mark law
Intellectual Property 2024-10-24 2:26 pm By Andy Sidler

The scope of protection for geographical indications will be at issue in India’s appeal of a decision that barred it from registering a trade mark for basmati rice.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

INPEX can cross-examine AkzoNobel’s lawyers over ‘inadequate’ discovery
Energy & Natural Resources 2024-10-23 11:14 pm By Cindy Cameronne

INPEX has won a bid to cross-examine AkzoNobel’s solicitors about discovery at the end of an 11-week trial over allegedly defective paint used on the $45 billion Ichthys natural gas project. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

New battle in Lexapro patent war between Lundbeck, Sandoz
Appeals 2024-10-18 11:17 pm By Christine Caulfield

Novartis unit Sandoz is appealing a tribunal decision in favour of pharmaceutical company Lundbeck over a licence to sell a generic version of leading antidepressant Lexapro.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?